{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:27:44Z","timestamp":1792801664572,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005149","name":"National Cancer Center","doi-asserted-by":"publisher","award":["NCC201901B01"],"award-info":[{"award-number":["NCC201901B01"]}],"id":[{"id":"10.13039\/501100005149","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.arcmed.2025.103242","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T08:38:24Z","timestamp":1749285504000},"page":"103242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Rivaroxaban Prophylaxis in Peripherally Inserted Central Catheter-Related Thrombosis in Breast Cancer Patients"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9637-4220","authenticated-orcid":false,"given":"Die","family":"Sang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huachao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhi","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2025.103242_bib0001","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.arcmed.2025.103242_bib0002","first-page":"1127","article-title":"A model to assess the risk of peripherally inserted central venous catheter-related thrombosis in patients with breast cancer: a retrospective cohort study","volume":"30","author":"Peng","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.arcmed.2025.103242_bib0003","first-page":"838","article-title":"Exploration of the high-risk factors of catheter-related thrombosis in breast cancer","volume":"43","author":"Liu","year":"2021","journal-title":"Zhonghua Zhong Liu Za Zhi [Chinese journal of oncology]"},{"key":"10.1016\/j.arcmed.2025.103242_bib0004","first-page":"1100","article-title":"Venous thromboembolism risk and prophylaxis status of cancer inpatient","volume":"43","author":"Xu","year":"2021","journal-title":"Zhonghua Zhong Liu Za Zhi [Chinese journal of oncology]"},{"key":"10.1016\/j.arcmed.2025.103242_bib0005","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/bmjspcare-2019-002106","article-title":"Central catheter-associated deep vein thrombosis in cancer: clinical course, prophylaxis, treatment","volume":"11","author":"Marin","year":"2021","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.arcmed.2025.103242_bib0006","first-page":"8577","article-title":"Catheter-related thrombosis (CRT) in patients with solid tumors: a narrative review and clinical guidance for daily care","volume":"30","author":"Laguna","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.arcmed.2025.103242_bib0007","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1477-9560-11-21","article-title":"Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies","volume":"11","author":"Prins","year":"2013","journal-title":"Thromb J"},{"key":"10.1016\/j.arcmed.2025.103242_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.05.003","article-title":"Risk assessment models for PICC-related venous thrombosis in adult patients with cancer: a network meta-analysis","volume":"239","author":"Hu","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.arcmed.2025.103242_bib0009","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/NCC.0000000000000742","article-title":"Complications and costs of peripherally inserted Central venous catheters compared with implantable port catheters for cancer patients: a meta-analysis","volume":"43","author":"Pu","year":"2020","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.arcmed.2025.103242_bib0010","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.addr.2011.06.012","article-title":"Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies","volume":"63","author":"Ekdahl","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.arcmed.2025.103242_bib0011","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1538-7836.2010.03771.x","article-title":"Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review","volume":"8","author":"Di Nisio","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.arcmed.2025.103242_bib0012","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.2010.08543.x","article-title":"Guideline on the investigation, management and prevention of venous thrombosis in children","volume":"154","author":"Chalmers","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.arcmed.2025.103242_bib0013","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1055\/s-0037-1613054","article-title":"Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic antithrombin replacement in kids with ALL treated with Asparaginase","volume":"87","author":"Male","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.arcmed.2025.103242_bib0014","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2025.103242_bib0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.6004\/jnccn.2024.0046","article-title":"Cancer-associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Streiff","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.arcmed.2025.103242_bib0016","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2147\/IJGM.S339583","article-title":"Assessment of risk factors and cognitive level associated with venous thrombosis patients in a coexistence of multiple diseases study in Shanghai","volume":"15","author":"Fan","year":"2022","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.arcmed.2025.103242_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.917572","article-title":"The incidence and risk of venous thromboembolism associated with peripherally inserted central venous catheters in hospitalized patients: a systematic review and meta-analysis","volume":"9","author":"Puri","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"2 Suppl","key":"10.1016\/j.arcmed.2025.103242_bib0018","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic Therapy and Prevention of thrombosis, 9th ed: american College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.arcmed.2025.103242_bib0019","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","article-title":"Comparison of an oral factor xa inhibitor with low molecular weight Heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D)","volume":"36","author":"Young","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2025.103242_bib0020","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.clinthera.2017.07.041","article-title":"Rivaroxaban in the treatment of PICC-associated upper extremity venous thrombosis","volume":"39","author":"Fan","year":"2017","journal-title":"Clin Ther"},{"key":"10.1016\/j.arcmed.2025.103242_bib0021","first-page":"256","article-title":"Mid-term analysis of prospective cohort study of rivaroxaban in preventing CRT in breast cancer","volume":"46","author":"Sang","year":"2024","journal-title":"Zhonghua Zhong Liu Za Zhi [Chinese journal of oncology]"},{"key":"10.1016\/j.arcmed.2025.103242_bib0022","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamainternmed.2021.6844","article-title":"Safety and outcomes of midline catheters vs peripherally inserted Central catheters for patients with short-term indications: a multicenter study","volume":"182","author":"Swaminathan","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.arcmed.2025.103242_bib0023","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.thromres.2020.01.017","article-title":"Central venous catheter-related thrombosis in children and adults","volume":"187","author":"Citla Sridhar","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.arcmed.2025.103242_bib0024","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2025.103242_bib0025","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamacardio.2022.1292","article-title":"Efficacy and safety considerations with dose-reduced direct oral anticoagulants: a review","volume":"7","author":"Bikdeli","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.arcmed.2025.103242_bib0026","first-page":"653","article-title":"Guidelines for the prevention and treatment of cancer-associated venous thromboembolism (2024 edition)","volume":"46","author":"Ma","year":"2024","journal-title":"Chinese Journal of Clinical Oncology"},{"key":"10.1016\/j.arcmed.2025.103242_bib0027","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/jpen.1609","article-title":"Epidemiology of infectious and noninfectious catheter complications in patients receiving home parenteral nutrition: a systematic review and meta-analysis","volume":"43","author":"Reitzel","year":"2019","journal-title":"JPEN J Parenter Enteral Nu"},{"key":"10.1016\/j.arcmed.2025.103242_bib0028","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","article-title":"Epidemiology of venous thromboembolism","volume":"12","author":"Heit","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.arcmed.2025.103242_bib0029","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archinte.1991.00400050081016","article-title":"A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study","volume":"151","author":"Anderson","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.arcmed.2025.103242_bib0030","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2025.103242_bib0031","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1538-7836.2010.04126.x","article-title":"Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta\u2013analysis of clinical trials and prospective studies","volume":"9","author":"Saber","year":"2011","journal-title":"J Thromb Haemos"},{"key":"10.1016\/j.arcmed.2025.103242_bib0032","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1378\/chest.10-0154","article-title":"Risk of symptomatic DVT associated with peripherally inserted central catheters","volume":"138","author":"Evans","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.arcmed.2025.103242_bib0033","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1538-7836.2007.02823.x","article-title":"Association between inherited thrombophilic abnormalities and central venous catheter thrombosis in patients with cancer: a meta-analysis","volume":"6","author":"Dentali","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.arcmed.2025.103242_bib0034","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(13)60592-9","article-title":"Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis","volume":"382","author":"Chopra","year":"2013","journal-title":"The Lancet"},{"key":"10.1016\/j.arcmed.2025.103242_bib0035","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3109\/10428190309178770","article-title":"Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures","volume":"44","author":"Cortelezzia","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.arcmed.2025.103242_bib0036","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1129729819852203","article-title":"Peripherally inserted central catheter-related thrombosis rate in modern vascular access era-when insertion technique matters: a systematic review and meta-analysis","volume":"21","author":"Balsorano","year":"2020","journal-title":"J Vasc Access"},{"key":"10.1016\/j.arcmed.2025.103242_bib0037","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s11239-024-02992-1","article-title":"Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study","volume":"57","author":"Linder","year":"2024","journal-title":"J Thromb Thrombolysis"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440925000621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440925000621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:55:07Z","timestamp":1758765307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440925000621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0188440925000621"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2025.103242","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rivaroxaban Prophylaxis in Peripherally Inserted Central Catheter-Related Thrombosis in Breast Cancer Patients","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2025.103242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of Instituto Mexicano del Seguro Social (IMSS).","name":"copyright","label":"Copyright"}],"article-number":"103242"}}